首页> Human vaccines & immunotherapeutics> Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.

导出 OA

翻译打印收藏纠错

第一作者： Wen-Hsiang,Chen

第一单位： Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development; National School of Tropical Medicine; Baylor College of Medicine; Houston, TX USA.

作者： Wen-Hsiang,Chen ^[1] ; Lanying,Du ^[2] ; Shivali M,Chag ^[1] ; Cuiqing,Ma ^[2] ; Nancy,Tricoche ^[2] ; Xinrong,Tao ^[3] ; Christopher A,Seid ^[1] ; Elissa M,Hudspeth ^[1] ; Sara,Lustigman ^[2] ; Chien-Te K,Tseng ^[3] ; Maria Elena,Bottazzi ^[1] ; Peter J,Hotez ^[1] ; Bin,Zhan ^[1] ; Shibo,Jiang ^[4]

作者单位： Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development; National School of Tropical Medicine; Baylor College of Medicine; Houston, TX USA. ^[1] Lindsley F Kimball Research Institute; New York Blood Center; New York, NY USA. ^[2] Department of Microbiology and Immunology; University of Texas Medical Branch; Galveston, TX USA. ^[3] Lindsley F Kimball Research Institute; New York Blood Center; New York, NY USA; Key Laboratory of Medical Molecular Virology of MOE/MOH; Shanghai Medical College and Institute of Medical Microbiology; Fudan University; Shanghai, PR China. ^[4]

关键词 SARS-CoV deglycosylation receptor-binding domain vaccine yeast expression